Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Optical coherence tomography should be part of the routine monitoring of patients with multiple sclerosis: Commentary.
A novel PEGylated interferon beta-1a for multiple sclerosis: safety, pharmacology, and biology.
Towards an endophenotype in multiple sclerosis.
Brain stem infarction associated with familial Mediterranean fever and central nervous system vasculitis.
Chronic Acquired Demyelinating Polyneuropathy following Renal Transplantation.
Metabotropic glutamate receptor 5 modulates calcium oscillation and innate immune response induced by lipopolysaccharide in microglial cell.
The atypical chemokine receptor ACKR2 suppresses Th17 responses to protein autoantigens.
Long-term safety of azathioprine therapy in multiple sclerosis.
A Comparative Analysis of Multiple Sclerosis-Relevant Anti-Inflammatory Properties of Ethyl Pyruvate and Dimethyl Fumarate.
Implications for multiple sclerosis in the era of the Affordable Care Act: a clinical overview.
Exosomes as nanocarriers for immunotherapy of cancer and inflammatory diseases.
Neuroprotective arylpiperazine dopaminergic/serotonergic ligands suppress experimental autoimmune encephalomyelitis in rats.
Genetic contribution to multiple sclerosis risk among Ashkenazi Jews.
The Development of Prophylactic and Therapeutic EBV Vaccines.
How scientists fool themselves - and how they can stop.
Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective series.
A Perspective on Roles Played by Innate and Adaptive Immunity in the Pathobiology of Neurodegenerative Disorders.
Autologous Haematopoietic Stem Cell Transplantation (AHSCT) for Aggressive Multiple Sclerosis - whom, when and how.
UNUSUAL CLINICAL CASES THAT MIMIC ACUTE DISSEMINATED ENCEPHALOMYELITIS.
Evaluation of locomotor function and microscopic structure of the spinal cord in a mouse model of experimental autoimmune encephalomyelitis following treatment with syngeneic mesenchymal stem cells.
Validation of the Serbian Version of Multiple Sclerosis Spasticity Scale 88 (MSSS-88).
Rabies encephalomyelitis vs. ADEM: Usefulness of MR imaging in differential diagnosis.
Achieving valid patient-reported outcomes measurement: a lesson from fatigue in multiple sclerosis.
Longitudinal 7-year follow-up of chronic pain in persons with multiple sclerosis in the community.
Mechanisms of Oxidative Damage in Multiple Sclerosis and Neurodegenerative Diseases: Therapeutic Modulation via Fumaric Acid Esters.
Pages
« first
‹ previous
…
560
561
562
563
564
565
566
567
568
…
next ›
last »